Navigation Links
New clinical guideline for low-back pain
Date:10/2/2007

A summary of evidence on the diagnosis and treatment of low-back pain has prompted the American Pain Society (ASP) and the American College of Physicians (ACP) to issue a new treatment guideline. The guideline is based on a thorough analysis of published research conducted by investigators at the Oregon Evidence-Based Practice Center at Oregon Health & Science University.

Among the recommendations issued by a panel of experts convened by the ACP and ASP are: Clinicians should rely less on X-rays and expensive diagnostic imaging and reports and more on therapies support by the evidence, including some medications and some alternative therapies. The guideline and two background papers are published in the October issue of the Annals of Internal Medicine.

There is good evidence that clinicians should not order X-rays or other imaging tests for patients with nonspecific low-back pain. They are not helpful and could result in excessive radiation exposure or unnecessary procedures, said Roger Chou, M.D., co-author of the new guidelines, senior author of both background papers, and associate professor of medicine (general internal medicine and geriatrics) and medical informatics and clinical epidemiology in the OHSU School of Medicine, Oregon Evidence-Based Practice Center at OHSU.

That said, clinicians should order diagnostic imaging tests for patients known or believed to have underlying neurological or spinal disorders, Chou explained. Chou also is head of the American Pain Societys Clinical Practice Guideline Program.

About one if four Americans experiences low-back pain at least once a day, resulting in more than $26 billion in direct health care costs, studies have shown. And low-back pain is the fifth most common reason patients make a doctors appointment.

The new guideline recommends clinicians weigh carefully potential benefits and risks of any drug and explain that they be used based on the severity of baseline pa
'/>"/>

Contact: Tamara Hargens-Bradley
hargenst@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...t of laws was initiated by Quebec Health Minister ...becers the option of private health-care insurance...tially struck down Quebec's ban on private insuran...ad failed to prove its ban on private health insur...
...bumani Ramadoss Friday warned of "strong action" a...elhi's All India Institute of Medical Sciences// (...s institution into a "political hub". "Some people...ical hub and action will be taken against them whe...
...rofessor Jonas Frisén who is at the Karolinska Ins...t which new cells are being produced// by individu...as published in the journal Cell. The research fee... drugs for diseases such as neurological disorders...
...ublished a report www.bmj.com which speaks of the ... born to women with diabetes. // They have caution... of women suffering diabetes shows no improvement....after birth (perinatal mortality) and congenital a...
Other Medicine News:Health News:Quebecers To Choose Private Health-Care Insurance 2Health News:Mechanism of Stem Cell Regulation Identified 2Health News:Diabetic women may suffer a complicated pregnancy 2
(Date:9/4/2008)...., Sept. 4 /- Southern Research Insti...of Health (NIH) has selected,the organization to p...,Probe Production Center Network (MLPCN). The MLPC...f the Molecular Libraries Program which is,designe...ledge of the human,genome and validate future targ...
(Date:9/4/2008)...land, September 4 /- Axentis Pharma A...ss the safety and tolerability,of a new therapeuti...y,infection in cystic fibrosis patients. The new f... to be delivered directly to the site of,infection...cts of two,different doses of the new drug. Initia...
(Date:9/4/2008)...onstrates potent antiviral activity and favorable ...AMBRIDGE, Mass., Sept. 4 /-...biopharmaceutical company engaged,in the discovery...an viral,and other infectious diseases, today anno...tudy evaluating IDX899, a non-nucleoside reverse,t...
(Date:9/4/2008)...ts Remain on Schedule with Two Abstracts Accepted ...ase in November 2008, BRIDGEWATER, N.J., Sept. 4 ...specialty pharmaceutical company focused on the tr...oday announced the appointment of,Peter L. Garramb...ter Garrambone,s career includes more than 50 phar...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2We Care Health Services Inc partners with IgeaCare Systems Inc to deliver Healthanywhere 28TM 29 for Chronic Disease Management in Canada 13806 1We Care Health Services Inc partners with IgeaCare Systems Inc to deliver Healthanywhere 28TM 29 for Chronic Disease Management in Canada 13806 2We Care Health Services Inc partners with IgeaCare Systems Inc to deliver Healthanywhere 28TM 29 for Chronic Disease Management in Canada 13806 3New stem cell technique improves genetic alteration 13803 1New stem cell technique improves genetic alteration 13803 2New stem cell technique improves genetic alteration 13803 3IPC The Hospitalist Company Inc to Report Fourth Quarter and Year End 2007 Financial Results 13800 1IPC The Hospitalist Company Inc to Report Fourth Quarter and Year End 2007 Financial Results 13800 2iCAD to Feature New Products and Capabilities at European Congress of Radiology 3794 1iCAD to Feature New Products and Capabilities at European Congress of Radiology 3794 2iCAD to Feature New Products and Capabilities at European Congress of Radiology 3794 3
...lif., April 16, 2007 /PRNewswire-FirstCall/ -- Kos...nical data on,KOS-1803, a next-generation epothilo... a favorable pharmacokinetic and safety,profile in...r,models. KOS-1803 has been chemically engineered ...hich has been shown in models to,result in excelle...
...tion Demonstrated in Lung and Colorectal Cancers, ...ll/ --,EntreMed, Inc. , a clinical-stage pharmaceu...tment of cancer and inflammatory diseases,announc... tubulin,inhibitor compounds. The data were presen...tion for Cancer Research (AACR) Annual,Meeting in ...
Other Medicine Technology:Kosan Presents Preclinical Antitumor and Safety Data On,Next-Generation Epothilone KOS-1803 at AACR 2Kosan Presents Preclinical Antitumor and Safety Data On,Next-Generation Epothilone KOS-1803 at AACR 3EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 2EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 3EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 4
...demand environments like OB/GYN, ER/Trauma, ICC/CC... delivers precision and control, plus consistent h...FESKIN* SATIN PLUS* Sterile Singles delive...excellent tactile sensitivity. The gloves are powd...
UROLOGY DRAPE. Soft translucent material for excellent shape conformity. Latex finger cot with additional adhesive ring around base. Full-width 50mm adhesive strip for secure fixing, with finger lift
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification
...the Penilab IV and the Penilab V have an exception...al studies. Model 1060 is similar to the Model 10...can one be added later. The Penilab V has a Doppl...of the accessories you'll need to get started. La...
Medicine Products: